NCT06360640View on ClinicalTrials.gov

A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 2, 2024

Primary Completion Date

March 10, 2025

Study Completion Date

March 10, 2025

Conditions
Healthy Subjects
Interventions
DRUG

APC148 and Placebo

IV infusion

Trial Locations (1)

Unknown

Clinical Trial Consultants AB, Uppsala

Sponsors

Lead Sponsor

AdjuTec Pharma AS
All Listed Sponsors
collaborator

CTC Clinical Trial Consultants AB

INDUSTRY

lead

AdjuTec Pharma AS

INDUSTRY